Gastroretentive drug delivery system of ranitidine hydrochloride based on osmotic technology: Development and evaluation

Current Drug Delivery

Volumn 5, Issue 4, 2008, Pages 332-342

  Kumar, P ^a   Singh, S ^a   Mishra, B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Floating; Gastroretentive; Hydrophilic polymer; Osmotic system; Ranitidine

Indexed keywords

CITRIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 400; PHTHALIC ACID DIBUTYL ESTER; RANITIDINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; OSMOTIC PRESSURE; OSMOTIC PUMP; PRIORITY JOURNAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CITRIC ACID; DRUG DELIVERY SYSTEMS; DRUG STABILITY; OSMOSIS; PLASTICIZERS; POLYMERS; RANITIDINE; SOLUBILITY; STOMACH;

EID: 55049121462     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720108785914943     Document Type: Article

References (34)

1. Grant, S. Drugs, 1989, 37, 801.
2. Lauritsen, K. Clin. Pharmacokinetic, 1990, 64, 94.
3. Rx list-The internet drug index, http://www.rxlist.com/cgi/generic/ranit. htm; Accessed on 27 July, 2007.
4. Basit, A.W.; Lacey, L.F. Int. J. Pharm., 2001, 227, 157.
5. Arora, S.; Ali, J.; Ahuja, A.; Khar, R.K.; Baboota, S. AAPS Pharm. Sci. Tech., 2005, 6, 372.
6. Singh, B.N.; Kim, K.H. J. Control. Release, 2000, 63, 235.
7. Coffin, M.; Parr, A. U.S. Patent No. 5407687, 1995.
8. Ponchel, G.; Irache, J.M. Adv. Drug Deliv. Rev., 1998, 34, 191.
9. Chen, J.; Park, H.; Park, K. J. Biomed. Mater. Res., 1999, 44, 53.
10. Rajinikanth, P.S.; Balasubramaniam, J.; Mishra, B. Int. J. Pharm., 2007, 335, 114.
11. Sheth, P.R.; Tossounian, J. Drug Dev. Ind. Pharm., 1984, 10, 313.
12. Fix, J.A.; Cargill, R.; Engle, K. Pharm. Res., 1993, 10, 1087.
13. Groning, R.; Heun, C. Drug Dev. Ind. Pharm., 1984, 10, 527.
14. Verma, R.K.; Mishra, B.; Garg, S. Drug Dev. Ind. Pharm., 2000, 26, 695.
15. Kumar, P.; Singh, S.; Rajinikanth, P.S.; Mishra, B. J. Pharm. Res., 2006, 5, 34.
16. Ramakrishna, N.; Mishra, B. Drug Dev. Ind. Pharm., 2002, 28, 403.
17. Krishnaiaha, Y.S.R.; Satyanarayana, V.; Bhaskar, P.R.; Karthikeyan, R.S. Int. J. Pharm., 2002, 236, 43.
18. Ozdemir, N.; Sahin, J. Int. J. Pharm., 1997, 158, 91.
19. Farthing, D.; Brouwer, K.L.R.; Fakhry, I.; Sica, D. J. Chromat. B., 1997, 688, 350.
20. Chavanpatil, M.; Jain, P.; Chaudhari, S.; Shear, R.; Vavia, P. Int. J. Pharm., 2005, 304, 178.
21. Srivastava, A.K.; Wadhwa, D.; Ridhurkar, D.; Mishra, B. Drug Dev. Ind. Pharm., 2005, 31, 367.
22. Costa, P.; Lobo, J. M.S. Eur. J. Pharm. Sci., 2001, 13, 123.
23. Ritschel, W.A. Drug Dev. Ind. Pharm., 1989, 15, 1073.
24. Sheskey, P.; Pacholke, K.; Sackett, G.; Maher, L.; Polli, J. Pharm. Tech., 2000, 24, 30.
25. Sheskey, P.; Sackett, G.; Maher, L.; Lentz, K.; Tolle, S.; Polli, J. Pharmaceutical Technology Tableting and Granulation Yearbook, New York, 1999, pp 6-21.
26. Electronic Orange Book, [On-line]. URL: http://www/fda.gov.in/gov/ cder/ob, accessed on July 20, 2007.
27. Regenthal, R.; Krueger, M.; Koeppel, C.; Preiss, R. J. Clin. Monit., 1999, 15, 529.
28. Santus, G.; Baker, W.R. J. Control. Release, 1995, 35, 1.
29. Verma, R.K.; Garg, S. Pharm. Tech., 2001, 25, 1.
30. Theeuwes, F. J. Pharm. Sci., 1975, 64, 1987.
31. Prabakaran, D.; Singh, P.; Kanaujia, P.; Vyas, S.P. Int. J. Pharm., 2003, 259, 173.
32. European Union Risk Assessment Report: Di-butylphthalate [Online] http://www.greenfacts.org/phthalates/dbp-dibutyl-phthalate; Accessed on 28 July 27, 2007.
33. Kumar, D.; Raman, M.V.; Singh, U.V.S.; Himaja, M.; Agarwal, A.; Garg, V.; Pabreja, K. Curr. Drug Deliv., 2007, 4, 21.
34. Bhimte, N.A.; Tayade, P.T. APPS Pharm. Sci. Tech., 2007, 8, 1.